Former Chief Medical Officer · Voyager Therapeutics, Inc. (VYGR)

Toby Ferguson

FY2025 is the first fiscal year CompBrief holds for Toby Ferguson as a named executive officer of Voyager Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,364,420

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Toby Ferguson compensation by year

Voyager Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Voyager Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$513,369
Bonus$0
Stock awards$265,860
Option awards$366,660
Non-equity incentive$202,781
Pension and deferred compensation$0
All other$15,750
Total$1,364,420

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Voyager Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001104659-26-050297, and prior-year filings. Open the filing on EDGAR.

Voyager Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Alfred SandrockChief Executive Officer, President, and Director$2,508,370
Jacquelyn Fahey SandellFormer Chief Legal Officer$1,474,986
Robin SwartzChief Business Officer & Chief Operating Officer$1,454,300
Toby Ferguson · this pageFormer Chief Medical Officer$1,364,420

The full Voyager Therapeutics compensation record

free company brief

This page is one person within Voyager Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Voyager Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Voyager Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy